24-24 April 2023
Qmed+
REGISTER NOW
keyboard_arrow_left See all news

Recent News

30 Jan, 2023 /
Cirtec Medical
Cirtec Medical Acquires QMD™ Precision Components Business
Cirtec Medical Corporation acquires QMD’s Precision Components business
27 Jan, 2023 /
AMADA WELD TECH
AMADA WELD TECH to Highlight Innovative Solutions for Medical Device Manufacturing at MD&M West 2023
Reliability, quality, and innovation on display in booth #2935
10 Jan, 2023 /
Qosina
Qosina introduces Irradiate to Order service for single-use bioprocess components
Qosina introduces an Irradiate to Order service for its single-use bioprocess component ...
09 Jan, 2023 /
Qosina
Qosina Announces Partnership with ILC Dover and Expanded Portfolio of Liquid Bag Chambers
Qosina announces a partnership with ILC Dover, a leader in the innovative design and pro...
05 Jan, 2023 /
Life Science Outsourcing, Inc.
Life Science Outsourcing Completes Acquisition of J-Pac Medical
Expands into biomaterials and diagnostics end-markets, broadens service offerings, and s...
Phillips-Medisize, a Molex company
/ 09 Apr, 2019
keyboard_arrow_left See all news

Phillips-Medisize Announces Expansion of Significant Medical Customer for Molex Little Rock Facility

HUDSON, WI – January 18, 2018 – phillipsmedisize – Phillips-Medisize, a Molex company, announces the expansion of a significant medical customer for the Molex Little Rock facility. The long-time customer is a leader in consumable diagnostics cancer testing, with its take-home diagnostic kit for cancer detection.

This is an exciting expansion for both the customer and Phillips-Medisize as it will double production, as the device is currently being produced in the Phillips-Medisize New Richmond facility. A second set of molding and dedicated automation machines to package and assemble the device will now be needed for the expanded production footprint in Little Rock.

Phillips-Medisize will mold, assemble with high speed automation, package and label the patient-ready device in the newly registered FDA facility, with production expected to begin in Q2 2018. This product will also include reagent handling and require unique device identification (UDI). Phillips-Medisize will utilize the number of the highly trained and qualified staff that already exists in the Little Rock operation.

The Little Rock facility establishes a new manufacturing site for Phillips-Medisize's medical business with capabilities for filling, drug handling, electronics and connected devices. This investment aims to combine the innovative solutions and knowledge of Molex's existing high volume automated electronics production operations with Phillips-Medisize's proven platform of drug delivery and medical device expertise.

Matt Jennings, CEO and President of Phillips-Medisize comments, “We are looking forward to expanding production with our customer and partnering with the Molex Little Rock team on this program. The team provides decades of experience in molding and assembly operations, cutting edge automation and quality control technology, as well as instant access to a team of highly talented and knowledgeable employees. We believe that Little Rock is the right location for our customer and will support both of our ambitious growth plans.”

Processing. Please wait.
Loading...